お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
949785

ヒューマンエンハンスメントの世界市場:技術別、用途別の業界の規模、シェア、成長性分析と予測

Human Enhancement Market Research Report: By Technology (Exoskeletons, Smart Devices, Medical Devices, Implants), Application (Healthcare, Defense, Industrial) - Industry Size, Share, and Growth Analysis Forecast to 2030

出版日: | 発行: Prescient & Strategic Intelligence Private Limited | ページ情報: 英文 194 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
ヒューマンエンハンスメントの世界市場:技術別、用途別の業界の規模、シェア、成長性分析と予測
出版日: 2020年04月01日
発行: Prescient & Strategic Intelligence Private Limited
ページ情報: 英文 194 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒューマンエンハンスメント(人間強化)市場は、2019年の648億米ドルから2030年には2,716億米ドルに拡大すると予測されており、2020年から2030年までのCAGRは14.7%になる見通しです。近年高齢者人口の増加と骨に問題を抱える若年層の増加などを背景に、整形外科リハビリテーションセンターで使用される歩行機能回復訓練機器の使用が拡大しており、センサーを使用して患者の動きを追跡し、より良いサポートを提供するロボット外骨格スーツの導入も進んでいます。また、神経障害および慢性疾患の有病率の増加に伴い、インプラントや補綴物、特にアクティブセンサーベースのインプラントに対する需要が高まっています。

当レポートは、世界のヒューマンエンハンスメント市場を調査したもので、世界と各地域市場の規模と予測、技術別、用途別の分析、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 調査の背景

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 市場セグメントの定義
    • 技術別
      • 外骨格スーツ
      • スマートデバイス
      • 医療機器
      • インプラント
    • 用途別
      • 医療
      • 防衛
      • 工業
      • その他
  • バリューチェーン分析
  • 市場力学
    • 動向
      • 健康的なライフスタイルを目的としたウェアラブル機器導入に対する意識の高まり
      • 医療技術の進歩
    • 成長促進要因
      • リハビリセンターでの外骨格スーツの利用拡大
      • 神経疾患の症例の増加
      • 市場予測に対する成長要因の影響分析
    • 成長阻害要因
      • 外骨格の高コストと移植性の問題
      • 市場予測に対する阻害要因の影響分析
    • 市場機会
      • 自動車メーカーでの外骨格スーツの利用拡大
      • 視覚障害者向けバイオニックレンズの普及拡大
  • ポーターのファイブフォース分析

第5章 世界市場の規模と予測

  • 技術別
    • 外骨格スーツ、身体部位別
    • 外骨格スーツ、フォーム別
    • 外骨格スーツ、作動技術別
    • スマートデバイス
    • 医療機器
    • インプラント
  • 用途別
  • 地域別

第6章 北米市場の規模と予測

  • 技術別
  • 用途別
  • 国別

第7章 欧州市場の規模と予測

  • 技術別
  • 用途別
  • 国別

第8章 アジア太平洋市場の規模と予測

  • 技術別
  • 用途別
  • 国別

第9章 他の地域市場の規模と予測

  • 技術別
  • 用途別
  • 国別

第10章 競合情勢

  • 主要企業とオファリングのリスト
  • 主要企業のランキング
  • 主要企業の競合ベンチマーキング
  • 主要企業の戦略的動向
    • 合併と買収
    • 提携
    • 製品の発売
    • 顧客獲得

第11章 企業プロファイル

  • ReWalk Robotics Ltd.
  • Cyberdyne Inc.
  • Medtronic plc
  • OMRON Corporation
  • Cochlear Ltd.
  • Ekso Bionics Holdings Inc.
  • Vuzix Corporation
  • Garmin Ltd.
  • Fitbit Inc.
  • Google LLC
  • Stryker Corporation
  • Zimmer Biomet Holdings Inc.
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Xiaomi Corporation
  • Apple Inc.

第12章 付録

  • 略語
  • 参考資料
  • 関連レポート
図表

List of Tables

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 GLOBAL HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 5 GLOBAL HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 6 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2019)
  • TABLE 7 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2020-2030)
  • TABLE 8 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2019)
  • TABLE 9 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2020-2030)
  • TABLE 10 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2019)
  • TABLE 11 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2020-2030)
  • TABLE 12 GLOBAL HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 13 GLOBAL HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 14 GLOBAL HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 15 GLOBAL HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 16 GLOBAL HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 17 GLOBAL HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 18 GLOBAL HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 19 GLOBAL HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 20 GLOBAL HUMAN ENHANCEMENT MARKET, BY REGION, $M (2014-2019)
  • TABLE 21 GLOBAL HUMAN ENHANCEMENT MARKET, BY REGION, $M (2020-2030)
  • TABLE 22 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 23 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 24 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2019)
  • TABLE 25 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2020-2030)
  • TABLE 26 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2019)
  • TABLE 27 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2020-2030)
  • TABLE 28 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2019)
  • TABLE 29 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2020-2030)
  • TABLE 30 NORTH AMERICA HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 31 NORTH AMERICA HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 32 NORTH AMERICA HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 33 NORTH AMERICA HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 34 NORTH AMERICA HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 35 NORTH AMERICA HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 36 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 37 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 38 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 39 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 40 EUROPE HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 41 EUROPE HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 42 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2019)
  • TABLE 43 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2020-2030)
  • TABLE 44 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2019)
  • TABLE 45 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2020-2030)
  • TABLE 46 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2019)
  • TABLE 47 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2020-2030)
  • TABLE 48 EUROPE HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 49 EUROPE HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 50 EUROPE HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 51 EUROPE HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 52 EUROPE HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 53 EUROPE HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 54 EUROPE HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 55 EUROPE HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 56 EUROPE HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 57 EUROPE HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 58 APAC HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 59 APAC HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 60 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2019)
  • TABLE 61 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2020-2030)
  • TABLE 62 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2019)
  • TABLE 63 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2020-2030)
  • TABLE 64 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2019)
  • TABLE 65 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2020-2030)
  • TABLE 66 APAC HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 67 APAC HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 68 APAC HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 69 APAC HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 70 APAC HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 71 APAC HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 72 APAC HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 73 APAC HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 74 APAC HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 75 APAC HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 76 ROW HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2019)
  • TABLE 77 ROW HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2020-2030)
  • TABLE 78 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2019)
  • TABLE 79 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2020-2030)
  • TABLE 80 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2019)
  • TABLE 81 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2020-2030)
  • TABLE 82 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2019)
  • TABLE 83 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2020-2030)
  • TABLE 84 ROW HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 85 ROW HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 86 ROW HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2019)
  • TABLE 87 ROW HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2020-2030)
  • TABLE 88 ROW HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2019)
  • TABLE 89 ROW HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2020-2030)
  • TABLE 90 ROW HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 91 ROW HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 92 ROW HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 93 ROW HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 94 LIST OF PLAYERS AND THEIR OFFERINGS
  • TABLE 95 COMPETITIVE BENCHMARKING OF KEY PLAYERS
  • TABLE 96 REWALK ROBOTICS LTD. - AT A GLANCE
  • TABLE 97 REWALK ROBOTICS LTD. - KEY FINANCIAL SUMMARY
  • TABLE 98 CYBERDYNE INC. - AT A GLANCE
  • TABLE 99 CYBERDYNE INC. - KEY FINANCIAL SUMMARY
  • TABLE 100 MEDTRONIC PLC - AT A GLANCE
  • TABLE 101 MEDTRONIC PLC - KEY FINANCIAL SUMMARY
  • TABLE 102 OMRON CORPORATION - AT A GLANCE
  • TABLE 103 COCHLEAR LTD. - AT A GLANCE
  • TABLE 104 COCHLEAR LTD. - KEY FINANCIAL SUMMARY
  • TABLE 105 VUZIX CORPORATION - AT A GLANCE
  • TABLE 106 VUZIX CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 107 GARMIN LTD. - AT A GLANCE
  • TABLE 108 GARMIN LTD. - KEY FINANCIAL SUMMARY
  • TABLE 109 FITBIT INC. - AT A GLANCE
  • TABLE 110 FITBIT INC.- KEY FINANCIAL SUMMARY
  • TABLE 111 GOOGLE LLC - AT A GLANCE
  • TABLE 112 STRYKER CORPORATION - AT A GLANCE
  • TABLE 113 STRYKER CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 114 ZIMMER BIOMET HOLDINGS INC. - AT A GLANCE
  • TABLE 115 ZIMMER BIOMET HOLDINGS INC. - KEY FINANCIAL SUMMARY
  • TABLE 116 JOHNSON & JOHNSON - AT A GLANCE
  • TABLE 117 JOHNSON & JOHNSON - KEY FINANCIAL SUMMARY
  • TABLE 118 BOSTON SCIENTIFIC CORPORATION - AT A GLANCE
  • TABLE 119 BOSTON SCIENTIFIC CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 120 XIAOMI CORPORATION - AT A GLANCE
  • TABLE 121 XIAOMI CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 122 APPLE INC. - AT A GLANCE
  • TABLE 123 APPLE INC. - KEY FINANCIAL SUMMARY

List of Figures

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL HUMAN ENHANCEMENT MARKET SUMMARY
  • FIG 9 VALUE CHAIN ANALYSIS OF GLOBAL HUMAN ENHANCEMENT MARKET
  • FIG 10 BARGAINING POWER OF BUYERS
  • FIG 11 BARGAINING POWER OF SUPPLIERS
  • FIG 12 INTENSITY OF RIVALRY
  • FIG 13 THREAT OF NEW ENTRANTS
  • FIG 14 THREAT OF SUBSTITUTES
  • FIG 15 GLOBAL HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 16 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2030)
  • FIG 17 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2030)
  • FIG 18 GLOBAL HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2030)
  • FIG 19 GLOBAL HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 20 GLOBAL HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 21 GLOBAL HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 22 GLOBAL HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 23 WORLDWIDE MAJOR MARKETS FOR HUMAN ENHANCEMENT DEVICES
  • FIG 24 GLOBAL HUMAN ENHANCEMENT MARKET, BY REGION, $M (2014-2030)
  • FIG 25 NORTH AMERICA HUMAN ENHANCEMENT MARKET SNAPSHOT
  • FIG 26 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 27 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2030)
  • FIG 28 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2030)
  • FIG 29 NORTH AMERICA HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2030)
  • FIG 30 NORTH AMERICA HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 31 NORTH AMERICA HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 32 NORTH AMERICA HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 33 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 34 NORTH AMERICA HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 35 EUROPE HUMAN ENHANCEMENT MARKET SNAPSHOT
  • FIG 36 EUROPE HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 37 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2030)
  • FIG 38 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2030)
  • FIG 39 EUROPE HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2030)
  • FIG 40 EUROPE HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 41 EUROPE HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 42 EUROPE HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 43 EUROPE HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 44 EUROPE HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 45 APAC HUMAN ENHANCEMENT MARKET SNAPSHOT
  • FIG 46 APAC HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 47 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2030)
  • FIG 48 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2030)
  • FIG 49 APAC HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2030)
  • FIG 50 APAC HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 51 APAC HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 52 APAC HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 53 APAC HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 54 APAC HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 55 ROW HUMAN ENHANCEMENT MARKET SNAPSHOT
  • FIG 56 ROW HUMAN ENHANCEMENT MARKET, BY TECHNOLOGY, $M (2014-2030)
  • FIG 57 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY BODY PART, $M (2014-2030)
  • FIG 58 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY FORM, $M (2014-2030)
  • FIG 59 ROW HUMAN ENHANCEMENT EXOSKELETON MARKET, BY ACTUATION, $M (2014-2030)
  • FIG 60 ROW HUMAN ENHANCEMENT SMART DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 61 ROW HUMAN ENHANCEMENT MEDICAL DEVICES MARKET, BY TYPE, $M (2014-2030)
  • FIG 62 ROW HUMAN ENHANCEMENT IMPLANTS MARKET, BY TYPE, $M (2014-2030)
  • FIG 63 ROW HUMAN ENHANCEMENT MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 64 ROW HUMAN ENHANCEMENT MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 65 RANKING OF KEY PLAYERS IN GLOBAL HUMAN ENHANCEMENT MARKET (2019)
  • FIG 66 REWALK ROBOTICS LTD. - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 67 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 68 OMRON CORPORATION - KEY FINANCIAL SUMMARY
  • FIG 69 OMRON CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 70 COCHLEAR LTD. - REVENUE SPLIT BY PRODUCT LINE AND GEOGRAPHY (2019)
  • FIG 71 EKSO BIONICS HOLDINGS INC. - AT A GLANCE
  • FIG 72 EKSO BIONICS HOLDINGS INC. - KEY FINANCIAL SUMMARY
  • FIG 73 EKSO BIONICS HOLDINGS INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 74 VUZIX CORPORATION - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 75 GARMIN LTD. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 76 FITBIT INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 77 STRYKER CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 78 ZIMMER BIOMET HOLDINGS INC. - REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2019)
  • FIG 79 JOHNSON & JOHNSON - REVENUE SPLIT BY BUSINESS SEGMENT AND GEOGRAPHY (2019)
  • FIG 80 BOSTON SCIENTIFIC CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 81 XIAOMI CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 82 APPLE INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
目次
Product Code: IM11945

"With the increase in the geriatric population and younger people suffering from bone-related issues, the footfall at orthopedic rehabilitation centers is surging. Here, exoskeletons are widely utilized to offer such people mobility support and help them regain their strength and motor functions. With time, the adoption of robotic exoskeletons has risen at such places, as they use sensors to track patients' movement and offer better support.

Thus, with the rising usage of exoskeletons, the human enhancement market is projected to grow from $64.8 billion in 2019 to over $271.6 billion by 2030, at a CAGR of 14.7% between 2020 and 2030 (forecast period). Seeing this, companies in the market are launching new and improved exoskeleton systems, which not only help those with bone issues, but also with brain and spine issues.

Implants to be Largest Technology throughout Forecast Period

Till 2030, implants are expected to keep holding the largest human enhancement market share, in terms of revenue. With the rise in the population of the elderly, the usage of implants and prosthetics is surging. Further, the increase in the prevalence of neurological disorders and chronic diseases has resulted in a high demand for active sensor-based implants. Similarly, the requirement for passive prosthetics and implants is surging, as more and more young people are suffering from orthopedic injuries.

Healthcare was the dominating category in the human enhancement market in 2019, as the spending on healthcare is radically growing in various countries. According to the Healthcare at a Glance report published by the Organisation for Economic Co-operation and Development (OECD) in 2019, around 10.2% of the global gross domestic product (GDP) is expected to be spent on healthcare in 2030, compared to 8.8% in 2018. Further, more people are buying connected wearable devices, which advise them on various aspects of their overall health and fitness.

In 2019, North America was the largest human enhancement market, as a result of its huge sales of medical devices, gesture control devices, wrist worn computers, head-mounted displays (HMDs), connected clothes and garments, and other such consumer electronics, 44.4 million units of which were shipped to users in the continent in 2018. During the forecast period, the highest CAGR, of 16.9%, would be experienced in Asia-Pacific (APAC), owing to the mushrooming uptake of connected wearable devices. This is itself a result of the widening reach of the internet and slump in the price of these devices.

Human Enhancement Market Players Focusing on Partnerships for Business Growth

In the past few years, several players in the human enhancement market have engaged in partnership, to leverage the opportunities created by:

Utilizing their partners' technology to make their devices better

Expanding their offerings portfolio

Combining their technologies to provide higher patient comfort

Widening their reach in new regions

Targeting customers in more industries than before

The major players in the human enhancement market are Google LLC, Magic Leap Inc., Vuzix Corporation, BrainGate Company, Ekso Bionics Holdings Inc., B-Temia Inc., Second Sight Medical Products Inc., Samsung Electronics Co. Ltd., ReWalk Robotics Ltd., Naked Prosthetics, Bionik Laboratories Corp., Raytheon Company, eSight Corp., Waverly Labs Inc., Solar Ear, Apple Inc., Microsoft Corporation, Cochlear Ltd., Parker Hannifin Corporation, TRS Inc., Steeper Group, Boston Scientific Corporation, Advanced Arm Dynamics Inc., Access Prosthetics, Johnson & Johnson, Garmin Ltd., Ortho Europe Limited, Cyberdyne Inc., Sony Corporation, Xiaomi Corporation, Sarcos Corp., Fitbit Inc., Stryker Corporation, Omron Corporation, Ekso Bionics Holdings Inc., Medtronic plc., and Zimmer Biomet Holdings Inc."

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Technology
    • 1.3.2 Market Segmentation by Application
    • 1.3.3 Market Segmentation by Region
    • 1.3.4 Analysis Period
    • 1.3.5 Market Data Reporting Unit
      • 1.3.5.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Technology
      • 4.1.1.1 Exoskeletons
        • 4.1.1.1.1 Body part
        • 4.1.1.1.1.1 Upper
        • 4.1.1.1.1.2 Lower
        • 4.1.1.1.1.3 Full body
        • 4.1.1.1.2 Form
        • 4.1.1.1.2.1 Hard
        • 4.1.1.1.2.2 Soft
        • 4.1.1.1.3 Actuation
        • 4.1.1.1.3.1 Electric
        • 4.1.1.1.3.2 Hydraulic
        • 4.1.1.1.3.3 Mechanical
      • 4.1.1.2 Smart Devices
        • 4.1.1.2.1 Smart watches and bands
        • 4.1.1.2.2 Smart clothing
        • 4.1.1.2.3 Fitness trackers
        • 4.1.1.2.4 Others
      • 4.1.1.3 Medical Devices
        • 4.1.1.3.1 Bionic lenses
        • 4.1.1.3.2 Hearing aids
        • 4.1.1.3.3 Others
      • 4.1.1.4 Implants
        • 4.1.1.4.1 Passive implants
        • 4.1.1.4.2 Active/sensor implants
        • 4.1.1.4.3 Brain enhancement implants
    • 4.1.2 By Application
      • 4.1.2.1 Healthcare
      • 4.1.2.2 Defense
      • 4.1.2.3 Industrial
      • 4.1.2.4 Others
  • 4.2 Value Chain Analysis
  • 4.3 Market Dynamics
    • 4.3.1 Trends
      • 4.3.1.1 Rising awareness toward adoption of wearables for healthy lifestyle
      • 4.3.1.2 Surging number of advancements in medical technologies
    • 4.3.2 Drivers
      • 4.3.2.1 Increasing utilization of exoskeletons in rehabilitation centers
      • 4.3.2.2 Rising cases of neurological disorders
      • 4.3.2.3 Impact analysis of drivers on market forecast
    • 4.3.3 Restraints
      • 4.3.3.1 High cost and portability issues of exoskeletons
      • 4.3.3.2 Impact analysis of restraints on market forecast
    • 4.3.4 Opportunities
      • 4.3.4.1 Increasing usage of exoskeletons by automotive manufacturing companies
      • 4.3.4.2 Rising implementation of bionic lenses for blind and visually impaired individuals
  • 4.4 Porter's Five Forces Analysis

Chapter 5. Global Market Size and Forecast

  • 5.1 By Technology
    • 5.1.1 Exoskeleton Market, by Body Part
    • 5.1.2 Exoskeleton Market, by Form
    • 5.1.3 Exoskeleton Market, by Actuation
    • 5.1.4 Smart Devices Market, by Type
    • 5.1.5 Medical Devices Market, by Type
    • 5.1.6 Implants Market, by Type
  • 5.2 By Application
  • 5.3 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Technology
    • 6.1.1 Exoskeleton Market, by Body Part
    • 6.1.2 Exoskeleton Market, by Form
    • 6.1.3 Exoskeleton Market, by Actuation
    • 6.1.4 Smart Devices Market, by Type
    • 6.1.5 Medical Devices Market, by Type
    • 6.1.6 Implants Market, by Type
  • 6.2 By Application
  • 6.3 By Country

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Technology
    • 7.1.1 Exoskeleton Market, by Body Part
    • 7.1.2 Exoskeleton Market, by Form
    • 7.1.3 Exoskeleton Market, by Actuation
    • 7.1.4 Smart Devices Market, by Type
    • 7.1.5 Medical Devices Market, by Type
    • 7.1.6 Implants Market, by Type
  • 7.2 By Application
  • 7.3 By Country

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Technology
    • 8.1.1 Exoskeleton Market, by Body Part
    • 8.1.2 Exoskeleton Market, by Form
    • 8.1.3 Exoskeleton Market, by Actuation
    • 8.1.4 Smart Devices Market, by Type
    • 8.1.5 Medical Devices Market, by Type
    • 8.1.6 Implants Market, by Type
  • 8.2 By Application
  • 8.3 By Country

Chapter 9. RoW Market Size and Forecast

  • 9.1 By Technology
    • 9.1.1 Exoskeleton Market, by Body Part
    • 9.1.2 Exoskeleton Market, by Form
    • 9.1.3 Exoskeleton Market, by Actuation
    • 9.1.4 Smart Devices Market, by Type
    • 9.1.5 Medical Devices Market, by Type
    • 9.1.6 Implants Market, by Type
  • 9.2 By Application
  • 9.3 By Country

Chapter 10. Competitive Landscape

  • 10.1 List of Players and Their Offerings
  • 10.2 Ranking of Key Players
  • 10.3 Competitive Benchmarking of Key Players
  • 10.4 Strategic Developments of Key Players
    • 10.4.1 Mergers & Acquisitions
    • 10.4.2 Partnerships
    • 10.4.3 Product Launches
    • 10.4.4 Client Wins

Chapter 11. Company Profiles

  • 11.1 ReWalk Robotics Ltd.
    • 11.1.1 Business Overview
    • 11.1.2 Product and Service Offerings
    • 11.1.3 Key Financial Summary
  • 11.2 Cyberdyne Inc.
    • 11.2.1 Business Overview
    • 11.2.2 Product and Service Offerings
    • 11.2.3 Key Financial Summary
  • 11.3 Medtronic plc
    • 11.3.1 Business Overview
    • 11.3.2 Product and Service Offerings
    • 11.3.3 Key Financial Summary
  • 11.4 OMRON Corporation
    • 11.4.1 Business Overview
    • 11.4.2 Product and Service Offerings
    • 11.4.3 Key Financial Summary
  • 11.5 Cochlear Ltd.
    • 11.5.1 Business Overview
    • 11.5.2 Product and Service Offerings
    • 11.5.3 Key Financial Summary
  • 11.6 Ekso Bionics Holdings Inc.
    • 11.6.1 Business Overview
    • 11.6.2 Product and Service Offerings
    • 11.6.3 Key Financial Summary
  • 11.7 Vuzix Corporation
    • 11.7.1 Business Overview
    • 11.7.2 Product and Service Offerings
    • 11.7.3 Key Financial Summary
  • 11.8 Garmin Ltd.
    • 11.8.1 Business Overview
    • 11.8.2 Product and Service Offerings
    • 11.8.3 Key Financial Summary
  • 11.9 Fitbit Inc.
    • 11.9.1 Business Overview
    • 11.9.2 Products and Services Offerings
    • 11.9.3 Key Financial Summary
  • 11.10 Google LLC
    • 11.10.1 Business Overview
    • 11.10.2 Product and Service Offerings
  • 11.11 Stryker Corporation
    • 11.11.1 Business Overview
    • 11.11.2 Product and Service Offerings
    • 11.11.3 Key Financial Summary
  • 11.12 Zimmer Biomet Holdings Inc.
    • 11.12.1 Business Overview
    • 11.12.2 Product and Service Offerings
    • 11.12.3 Key Financial Summary
  • 11.13 Johnson & Johnson
    • 11.13.1 Business Overview
    • 11.13.2 Product and Service Offerings
    • 11.13.3 Key Financial Summary
  • 11.14 Boston Scientific Corporation
    • 11.14.1 Business Overview
    • 11.14.2 Product and Service Offerings
    • 11.14.3 Key Financial Summary
  • 11.15 Xiaomi Corporation
    • 11.15.1 Business Overview
    • 11.15.2 Product and Service Offerings
    • 11.15.3 Key Financial Summary
  • 11.16 Apple Inc.
    • 11.16.1 Business Overview
    • 11.16.2 Product and Service Offerings
    • 11.16.3 Key Financial Summary

Chapter 12. Appendix

  • 12.1 Abbreviations
  • 12.2 Sources and References
  • 12.3 Related Reports
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.